CoChat

Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia

Open access
Zhao, Na, Qiao, Wenhui, Li, Fuyao, Ren, Yingxue, Zheng, Jiaying, Martens, Yuka A., Wang, Xusheng, Li, Ling, Liu, Chia-Chen, Chen, Kai, Zhu, Yiyang, Ikezu, Tadafumi C., Li, Zonghua, Meneses, Axel D., Jin, Yunjung, Knight, Joshua A., Chen, Yixing, Bastea, Ligia, Linares, Cynthia, Sonustun, Berkiye, Job, Lucy, Smith, Madeleine L., Xie, Manling, Liu, Yong U., Umpierre, Anthony D., Haruwaka, Koichiro, Quicksall, Zachary S., Storz, Peter, Asmann, Yan W., Wu, Long-Jun, Bu, Guojun · 2022 · Journal of Experimental Medicine
Cited by 111

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

TREM2 is exclusively expressed by microglia in the brain and is strongly linked to the risk for Alzheimer’s disease (AD). As microglial responses modulated by TREM2 are central to AD pathogenesis, enhancing TREM2 signaling has been explored as an AD therapeutic strategy. However, the effective therapeutic window targeting TREM2 is unclear. Here, by using microglia-specific inducible mouse models overexpressing human wild-type TREM2 (TREM2-WT) or R47H risk variant (TREM2-R47H), we show that TREM2-WT expression reduces amyloid deposition and neuritic dystrophy only during the early amyloid seeding stage, whereas TREM2-R47H exacerbates amyloid burden during the middle amyloid rapid growth stage. Single-cell RNA sequencing reveals suppressed disease-associated microglia (DAM) signature and reduced DAM population upon TREM2-WT expression in the early stage, whereas upregulated antigen presentation pathway is detected with TREM2-R47H expression in the middle stage. Together, our findings highlight the dynamic effects of TREM2 in modulating AD pathogenesis and emphasize the beneficial effect of enhancing TREM2 function in the early stage of AD development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20212479

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 111

Metadata

Authors
Zhao, N., Qiao, W., Li, F., Ren, Y., Zheng, J., Martens, Y. A., Wang, X., Li, L., Liu, C.-C., Chen, K., Zhu, Y., Ikezu, T. C., Li, Z., Meneses, A. D., Jin, Y., Knight, J. A., Chen, Y., Bastea, L., Linares, C., Sonustun, B., Job, L., Smith, M. L., Xie, M., Liu, Y. U., Umpierre, A. D., Haruwaka, K., Quicksall, Z. S., Storz, P., Asmann, Y. W., Wu, L.-J., & Bu, G.
Venue
Journal of Experimental Medicine
Published
2022-09-15
Volume
219
Issue
12
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W4295903538
Cited by
111
References
55
FWCI
5.84
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia. https://app.cochat.ai/papers/10.1084/jem.20212479
The paper
Zhao, N., Qiao, W., Li, F., Ren, Y., Zheng, J., Martens, Y. A., Wang, X., Li, L., Liu, C.-C., Chen, K., Zhu, Y., Ikezu, T. C., Li, Z., Meneses, A. D., Jin, Y., Knight, J. A., Chen, Y., Bastea, L., Linares, C., . . . Bu, G. (2022). Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20212479

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.